The classic receptor for 1?,25-dihydroxy vitamin D3 is required for non-genomic actions of 1?,25-dihydroxy vitamin D3 in osteosarcoma cells

Bravo S.; Paredes, R.; Izaurieta, P; Hinrichs M.V.; Olate, J; Montecino, M.; Aguayo, L. G.; Lian J.B.; Stein J.L.; Stein G.S.

Keywords: sequence, rat, membrane, animals, expression, rats, protein, cell, gene, calcium, genome, metabolism, genetics, receptor, regulation, level, rna, bone, drug, pathology, calcitriol, article, vitamin, activity, osteoblast, controlled, osteosarcoma, small, animal, study, nucleotide, derivative, priority, nonhuman, journal, Receptors,, RNA,, D, dihydroxy, D3, interfering, dihydroxy-vitamin

Abstract

1?,25-dihydroxy vitamin D3 has a major role in the regulation of the bone metabolism as it promotes the expression of key bone-related proteins in osteoblastic cells. In recent years it has become increasingly evident that in addition to its well-established genomic actions, 1?,25-dihydroxy vitamin D3 induces non-genomic responses by acting through a specific plasma membrane-associated receptor. Results from several groups suggest that the classical nuclear 1?,25-dihydroxy vitamin D3 receptor (VDR) is also responsible for these non-genomic actions of 1?,25-dihydroxy vitamin D3. Here, we have used siRNA to suppress the expression of VDR in osteoblastic cells and assessed the role of VDR in the non-genomic response to 1?,25-dihydroxy vitamin D3. We report that expression of the classic VDR in osteoblasts is required to generate a rapid 1?,25-dihydroxy vitamin D3-mediated increase in the intracellular Ca 2+ concentration, a hallmark of the non-genomic actions of 1?,25-dihydroxy vitamin D3 in these cells. © 2006 Wiley-Liss, Inc.

Más información

Título de la Revista: JOURNAL OF CELLULAR BIOCHEMISTRY
Volumen: 99
Número: 4
Editorial: Wiley
Fecha de publicación: 2006
Página de inicio: 995
Página final: 1000
URL: http://www.scopus.com/inward/record.url?eid=2-s2.0-33750568026&partnerID=q2rCbXpz